Skip to main content

Table 3 IC 50 values for eflornithine, melarsoprol, pentamidine and nifurtimox obtained with the T.b. gambiense 348BT wild type and the recombinant RLuc #2.1 strain assessed with EnduRen, CellTiter-Glo and resazurin

From: Luminescent multiplex viability assay for Trypanosoma brucei gambiense

Inoculum

Drug

IC50a

EnduRend

CellTiter-Gloe

Resazurinf

  

wild type

RLuc # 2.1

wild type

RLuc # 2.1

wildtype

RLuc # 2.1

5 x 103

eflornithineb

n.a.

1.0 ± 0.4

1.1 ± 0.4

1.0 ± 0.5

1.1 ± 0.6

1.4 ± 0.4

melarsoprolc

n.a.

5.5 ± 2.1

4.5 ± 2.2

5.0 ± 1.9

6.3 ± 3.0

6.5 ± 2.3

pentamidinec

n.a.

40.1 ± 11.1

43.6 ± 10.3

41.1 ± 7.5

67.5 ± 11.1

64.1 ± 13.6

nifurtimoxc

n.a.

334 ± 47

274 ± 93

380 ± 84

437 ± 139

410 ± 132

2 x 104

eflornithineb

n.a.

2.8 ± 0.5

3.0 ± 0.7

2.6 ± 1.0

2.6 ± 0.9

2.9 ± 0.7

melarsoprolc

n.a.

11.0 ± 3.2

12.0 ± 2.8

11.5 ± 2.6

8.9 ± 2.2

11.9 ± 2.6

pentamidinec

n.a.

47.5 ± 8.1

43.7 ± 10.8

48.9 ± 9.1

74.7 ± 12.3

72.5 ± 6.3

nifurtimoxc

n.a.

700 ± 63

670 ± 78

720 ± 75

751 ± 174

768 ± 125

  1. a values are the mean ± SD from 4 cultures.
  2. b reported in μg ml-1.
  3. c reported in ng ml-1.
  4. d luminescent assay for measurement of Renilla luciferase activity in living cells.
  5. e luminescent assay for quantification of ATP.
  6. f fluorimetric assay for measurement of reduction of resazurin.
  7. n.a. not applicable.